Literature DB >> 3213592

A chemiluminometric method for the determination of urea in serum using a three-enzyme bioreactor.

M Tabata1, T Murachi.   

Abstract

A flow injection chemiluminometric assay for urea has been developed based on a minicolumn bioreactor packed with immobilized enzyme-bearing glass beads. The reactor contains immobilized urease, L-glutamate dehydrogenase and L-glutamate oxidase, aligned in this order (upstream to the downstream). When the sample is introduced into the bioreactor, urea is first hydrolysed by urease to produce ammonia, which is then converted into L-glutamate by L-glutamate dehydrogenase. L-Glutamate is finally oxidized by L-glutamate oxidase to produce hydrogen peroxide, which is quantified by measuring chemiluminescence emitted upon admixing with luminol and potassium ferricyanide. One assay cycle is completed within 1 minute. The method is sensitive (detection limit 0.5 nmol) and is linear in the range 0-30 mmol/l. It can be readily applied to the determination of urea in human serum, and requires no blank corrections for ammonia and/or L-glutamate present in serum samples.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3213592     DOI: 10.1002/bio.1170020202

Source DB:  PubMed          Journal:  J Biolumin Chemilumin        ISSN: 0884-3996


  3 in total

1.  Short-term effects of lovastatin therapy on proteinuria of type 2 diabetic nephropathy: A clinical trial study.

Authors:  Alireza Sadighi; Javid Safa; Amir-Mansour Vatankhah; Sona Ghorashi; Aida Aharilahagh; Sina Davari-Farid; Ourmaan Nezami-Nargabad; Mohammad Naghavi-Behzad; Reza Piri; Parinaz Pishahang; Savalan Babapoor-Farrokhran; Sanam Fakour; Nastaran Ghodratnezhad-Azar
Journal:  Niger Med J       Date:  2016 Sep-Oct

2.  Effects of atorvastatin on proteinuria of type 2 diabetic nephropathy in patients with history of gestational diabetes mellitus: A clinical study.

Authors:  Fatemeh Abbasalizadeh; Parviz Saleh; Rana Dousti; Reza Piri; Mohammad Naghavi-Behzad; Shamsi Abbasalizadeh
Journal:  Niger Med J       Date:  2017 Mar-Apr

3.  Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy.

Authors:  Akshay Mohan; Sandeep Saxena; Apjit Kaur; Wahid Ali; Levent Akduman
Journal:  Mol Vis       Date:  2021-07-03       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.